Viva Biotech Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Viva Biotech Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Life Sciences earnings growth | 25.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Positive Sentiment Still Eludes Viva Biotech Holdings (HKG:1873) Following 27% Share Price Slump
Jan 19
Does Viva Biotech Holdings (HKG:1873) Have A Healthy Balance Sheet?
Jun 01These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt In A Risky Way
Sep 25Is It Too Late To Consider Buying Viva Biotech Holdings (HKG:1873)?
Jul 11These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt Extensively
Apr 14Is Now The Time To Look At Buying Viva Biotech Holdings (HKG:1873)?
Dec 23Is Viva Biotech Holdings (HKG:1873) Using Too Much Debt?
Nov 06Estimating The Intrinsic Value Of Viva Biotech Holdings (HKG:1873)
Jun 13We Think Viva Biotech Holdings (HKG:1873) Is Taking Some Risk With Its Debt
Apr 17Viva Biotech Holdings (HKG:1873) Shareholders Have Enjoyed A 55% Share Price Gain
Mar 13Need To Know: Viva Biotech Holdings (HKG:1873) Insiders Have Been Selling Shares
Feb 06What Percentage Of Viva Biotech Holdings (HKG:1873) Shares Do Insiders Own?
Jan 02Can You Imagine How Viva Biotech Holdings' (HKG:1873) Shareholders Feel About The 65% Share Price Increase?
Nov 21
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Viva Biotech Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 2,156 | -116 | N/A | N/A | N/A |
| 9/30/2023 | 2,284 | -276 | N/A | N/A | N/A |
| 6/30/2023 | 2,413 | -436 | 396 | 611 | N/A |
| 3/31/2023 | 2,396 | -482 | 266 | 498 | N/A |
| 12/31/2022 | 2,380 | -528 | 137 | 386 | N/A |
| 9/30/2022 | 2,283 | -209 | -96 | 269 | N/A |
| 6/30/2022 | 2,186 | 111 | -329 | 152 | N/A |
| 3/31/2022 | 2,145 | 199 | -409 | 115 | N/A |
| 12/31/2021 | 2,104 | 288 | -488 | 78 | N/A |
| 9/30/2021 | 1,815 | 258 | -619 | 59 | N/A |
| 6/30/2021 | 1,526 | 228 | -750 | 40 | N/A |
| 3/31/2021 | 1,111 | -79 | -662 | 42 | N/A |
| 12/31/2020 | 697 | -387 | -575 | 43 | N/A |
| 9/30/2020 | 538 | -349 | -308 | 49 | N/A |
| 6/30/2020 | 378 | -311 | -41 | 54 | N/A |
| 3/31/2020 | 351 | -23 | -28 | 50 | N/A |
| 12/31/2019 | 323 | 266 | -16 | 46 | N/A |
| 9/30/2019 | 299 | 176 | -27 | 31 | N/A |
| 6/30/2019 | 275 | 86 | -39 | 16 | N/A |
| 3/31/2019 | 243 | 88 | -37 | 14 | N/A |
| 12/31/2018 | 210 | 91 | -35 | 12 | N/A |
| 12/31/2017 | 148 | 76 | 9 | 28 | N/A |
| 12/31/2016 | 96 | 24 | N/A | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1873's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if 1873's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 1873's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 1873's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 1873's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1873's Return on Equity is forecast to be high in 3 years time